Study to Evaluate Effectiveness and Safety in Subjects With Moderate to Severe Psoriasis

PHASE2CompletedINTERVENTIONAL
Enrollment

268

Participants

Timeline

Start Date

November 15, 2016

Primary Completion Date

November 16, 2017

Study Completion Date

November 16, 2017

Conditions
Psoriasis
Interventions
DRUG

BMS-986165

DRUG

Placebo for BMS-986165

Trial Locations (76)

2217

Local Institution, Kogarah

3053

Local Institution, Melbourne

4102

Local Institution, Wolloongabba

6009

Local Institution, Nedlands

15831

Local Institution, Mahlow

19055

Local Institution, Schwerin

20253

Local Institution, Hamburg

20354

Local Institution, Hamburg

23538

Local Institution, Lübeck

24103

Local Institution, Kiel

24105

Local Institution, Kiel

27804

PMG Research of Rocky Mount, LLC, Rocky Mount

28277

Piedmont Plastic Surgery & Dermatology - Charlotte/Blakeney Location, Charlotte

28401

PMG Research of Wilmington, PLC, Wilmington

31217

Dermatologic Surgery Specialists, PC, Macon

34471

Renstar Medical Research, Ocala

37072

Rivergate Dermatology Clinical Research Center, Pllc, Goodlettsville

37920

Local Institution, Knoxville

45030

Local Institution, Zapopan

46256

Dawes Fretzin Clinical Research Group, LLC, Indianapolis

50368

Local Institution, Wroclaw

55131

Local Institution, Mainz

57702

Health Concepts, Rapid City

60077

NorthShore University Health System, Skokie

61820

PMG Research of Christie Clinic, LLC, Champaign

64460

Local Institution, Monterrey

70178

Local Institution, Stuttgart

73071

Central Sooner Research, Norman

78705

Austin Dermatology Associates, Austin

92122

University of California San Diego, San Diego

92697

University of California Irvine, Irvine

1690073

Local Institution, Skinjuku-ku

1738606

Local Institution, Tokyo

3290498

Local Institution, Shimotsuke-shi

4678602

Local Institution, Nagoya

5500012

Local Institution, Osaka

6500017

Local Institution, Kobe

8608556

Local Institution, Kumamoto

03756

Dartmouth-Hitchcock Medical Center-Norris Cotton Cancer Center, Lebanon

T2G 1B1

Local Institution, Calgary

T5K 1X3

Local Institution, Edmonton

V5Z 4E8

Local Institution, Vancouver

L8N 1Y2

Local Institution, Hamilton

L3P 1X2

Local Institution, Markham

L5H 1G9

Local Institution, Mississauga

K9J 5K2

Local Institution, Peterborough

M4W 2N2

Local Institution, Toronto

N2J 1C4

Local Institution, Waterloo

N8W 1E6

Local Institution, Windsor

H3H 1V4

Local Institution, Montreal

01097

Local Institution, Dresden

07548

Local Institution, Gera

814-0180

Local Institution, Fukuoka

060-0063

Local Institution, Sapporo

602-8566

Local Institution, Kamigyō-ku

105-8471

Local Institution, Minato-ku

141-8625

Local Institution, Shinagawa-Ku

160-0023

Local Institution, Shinjuku-ku

LV-5404

Local Institution, Daugavpils

LV-1001

Local Institution, Riga

LV-1003

Local Institution, Riga

LV-1011

Local Institution, Riga

LV-1013

Local Institution, Riga

LV3601

Local Institution, Ventspils

31-011

Local Institution, Krakow

90-436

Local Institution, Lodz

20-080

Local Institution, Lublin

86-031

Local Institution, Osielsko

08 - 110

Local Institution, Siedlce

96-100

Local Institution, Skierniewice

00-660

Local Institution, Warsaw

01-142

Local Institution, Warsaw

01-817

Local Institution, Warsaw

02-758

Local Institution, Warsaw

02-777

Local Institution, Warsaw

51-318

Local Institution, Wroc?aw

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY